2025 Plenary Keynote Sessions
Tuesday, March 11
8:00 am Chairperson's Remarks
Edward Abrahams, PhD, Former President, Personalized Medicine Coalition
8:05 am Plenary Keynote Introduction (Sponsorship Available)
8:15 am Plenary Keynote Fireside Chat: A New Era in Healthcare: Making Precision Medicine a Reality
Gabriele Allegri, MBA, Vice President, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine
Interviewed By:
Edward Abrahams, PhD, Former President, Personalized Medicine Coalition
8:45 am Panel Discussion: The Pharmaceutical Industry and Precision Medicine
Moderator:
Edward Abrahams, PhD, Former President, Personalized Medicine Coalition
Personalized or precision medicine depends upon linking prescribed therapies to diagnostics so that the right patient gets the right drug at the right time. Yet bringing the therapeutics and diagnostics together does not come easily as the pharmaceutical and diagnostic industries do not share the same business models or cultures. This panel discussion will explore what pharmaceutical executives look for when partnering with colleagues in diagnostics to develop targeted therapies.
Panelists:
Steffan Ho, MD, PhD, Vice President, Head of Translational Oncology, Pfizer
Andrea L. Stevens, PhD, Senior Director, Precision Medicine Access, J&J Innovative Medicine
Lourdes Barrera, PhD, Executive Director, Global Medical Affairs Oncology—Precision Medicine, Merck
Omar Perez, PhD, Head of Medical Diagnostics, US Medical Affairs Oncology, AstraZeneca
3:40 pm Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
3:45 pm Plenary Keynote Fireside Chat: Patient-Centric Innovation—Redefining At-Home Health Experiences
Peter Foley, Founder & CEO, LetsGetChecked
In this fireside chat, Peter Foley, CEO and founder of LetsGetChecked, will explore the mission and vision that have driven the company’s rapid growth and innovation in home health management. He will share insights into the journey of scaling from a direct-to-consumer model to a robust business-to-business platform, addressing the challenges of integrating health insights and advanced clinical diagnostics with exceptional customer care. From immunoassays and clinical chemistry to genomics, Peter will discuss how LetsGetChecked leverages cutting-edge technologies to empower precision medicine at scale, delivering tailored healthcare solutions that meet the unique needs of millions of individual patients. This conversation will highlight the transformative role of precision medicine, patient-focused care models, and innovative digital platforms in shaping a more connected and responsive healthcare ecosystem that delivers measurable value for all stakeholders.
Interviewed By:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
4:15 pm Panel Discussion: Driving Innovation in Precision Medicine: CEO Perspective
Moderator:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
Explore the cutting-edge of precision medicine through the eyes of leading diagnostics company CEOs. This panel will highlight how innovative companies are pushing the boundaries of innovation, addressing industry challenges, and shaping the future of personalized healthcare. Gain firsthand insights on the strategies driving breakthroughs and the critical leadership required to build a successful company and transform the landscape.
Panelists:
Lisa Alderson, CEO, Adela, Inc.
Alex Aravanis, MD, PhD, CEO, Moonwalk Biosciences
Susan Tousi, CEO, DELFI Diagnostics
Wednesday, March 12
8:00 am Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
8:05 am Plenary Keynote Introduction (Sponsorship Available)
8:15 am Panel Discussion: Investing in Precision Medicine Innovation: What Defines Success?
Moderator:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
Dive into the world of investing in precision medicine and explore what defines success in this ever-changing sector. This panel will unpack the key drivers behind successful investments, from proprietary technologies to regulatory challenges. Investors will share their perspectives on identifying high-impact opportunities, managing risk, and fostering innovation to achieve long-term value in precision medicine.
Panelists:
Ajit Singh, PhD, Partner, Artiman Ventures
Jenny Rooke, PhD, Managing Director, Genoa Ventures
Michael Hadjisavas, PhD, Executive Advisor, GreyBird Ventures LLC
4:15 pm Panel Discussion: Tech Trends in Precision Medicine
Moderator:
Jonathan D. Grinstein, PhD, North America Editor, Inside Precision Medicine
Leading technology companies will discuss future trends, needs, and solutions needed to drive precision medicine forward, including innovation in genomics and diagnostics, artificial intelligence and digital tech, multiomic analysis, biomarkers, and clinical trials.
Panelists
Aaron Sin, Senior Director Research & Technology Development, Diagnostics & Regulated Materials, MilliporeSigma
Shawn Carlson, Vice President, Head of Market Access, Roche Diagnostics
Damon Hostin, Lead, Market Access, Health Systems, Illumina, Inc.
Shawn Fahl, PhD, Vice President, Lab Operations, Cell Services & R&D, Biospecimens, Discovery Life Sciences
Suzanne Belinson, PhD, Vice President, Commercial Markets, Tempus, Inc.